Log in
Enquire now
‌

US Patent 9938267 Heterocyclic inhibitors of glutaminase

Patent 9938267 was granted and assigned to Calithera Biosciences on April, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Calithera Biosciences
Calithera Biosciences
0
Date Filed
September 11, 2017
0
Date of Patent
April 10, 2018
0
Patent Applicant
Calithera Biosciences
Calithera Biosciences
0
Patent Application Number
15700796
0
Patent Inventor Names
Guy Laidig
0
Timothy F. Stanton
0
Lijing Chen
0
Bindu Goyal
0
Eric B. Sjogren
0
Jim Li
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9938267
0
Patent Primary Examiner
‌
Alicia L Otton
0

Find more entities like US Patent 9938267 Heterocyclic inhibitors of glutaminase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.